| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |